Skip to content

BD² powers collaborative science to transform how bipolar disorder is understood and treated, supporting multidisciplinary teams that push discovery toward real‑world impact.

Science funding icon

Since launch, BD² has invested $105M+ in research commitments.

Funding Opportunities:
Requests for Applications (RFAs)

Showing 1 of 1 results.
Title Description Amount Year/Status RFA Links
Brain Omics Platform

Brain Omics Platform

The Brain Omics Platform analyzes a variety of epigenetic, transcriptomic, proteomic, and other omic characteristics of human brain tissue from people with bipolar disorder. Our partners conduct state-of-the-art research to develop the molecular atlas of neural and non-neural changes in people with bipolar disorder.

Amount: up to $5,000,000
for up to 3 years
Year/Status: 2022Inactive Download RFA